期刊论文详细信息
Journal of Pharmacological Sciences
Renal Protection of In Vivo Administration of Tempol in Streptozotocin-Induced Diabetic Rats
Huiling Gong3  Weiping Li3  Jiajie Luan3  Jia Han3  Rong Ma1  Wen Zhang2 
[1] Department of Integrative Physiology, University of North Texas Health Science Center, USA;Department of Pharmacy, Yijishan Hospital of Wannan Medical University, China;Department of Pharmacology, Anhui Medical University, China
关键词: diabetic nephropathy;    tempol;    transient receptor potential 6 (TRPC6);    transforming growth factor-β1;    collagen IV;   
DOI  :  10.1254/jphs.12002FP
学科分类:药学
来源: Nihon Yakuri Gakkai Henshuubu / Japanese Pharmacological Society
PDF
【 摘 要 】

References(57)Cited-By(6)The present study was carried out to investigate the protective effects of tempol on renal function and the underlying mechanism in streptozotocin-induced diabetic rats. The diabetic rats were randomly divided into the model group (without tempol) and tempol group (1 mM tempol in drinking water for 6 weeks). Nondiabetic rats were served as the Control group. The mRNA expression of canonical transient receptor potential 6 (TRPC6), transforming growth factor (TGF)-β1, and type IV collagen (Col IV) were examined. The malondialdehyde (MDA) level, activities of superoxide dismutase (SOD), and glutathione peroxidase (GSH-Px) in renal tissues were measured to assess redox status in kidneys. We found that tempol significantly reduced 24-h urine output and urine albuminuria excretion in the diabetic rats. Compared with the model group, the concentration of MDA was significantly lower in the tempol group. In addition, diabetes decreased activities of SOD and GSH-Px and these responses were prevented by tempol treatment. Moreover, in diabetic rats, the mRNA expression levels of TGF-β1 and Col IV were upregulated. TRPC6 mRNA expression level was down-regulated in diabetic kidneys. However, all of these diabetic effects were significantly suppressed by tempol treatment. These results suggest that chronic treatment of diabetic rats with tempol can protect kidneys, possibly by reducing expression of TGF-β1, Col IV, and upregulating TRPC6 expression level.

【 授权许可】

Unknown   

【 预 览 】
附件列表
Files Size Format View
RO201911300941235ZK.pdf 477KB PDF download
  文献评价指标  
  下载次数:9次 浏览次数:9次